From: Efficacy of postoperative pain management in head and neck cancer patients
Characteristic | Number of subjects (%) |
---|---|
Gender | |
Male | 32 (78%) |
Female | 9 (22%) |
Age (yrs) | |
Mean (SD) | 61.2 (12.3) |
Range | 23.6–82.0 |
Primary site | |
Oral Cavity | 23 (56%) |
Oropharynx | 3 (7%) |
Larynx | 4 (10%) |
Paranasal Sinus | 3 (7%) |
Skin | 3 (7%) |
Salivary Gland | 2 (5%) |
Other Site | 3 (7%) |
pT Classification | |
T0 | 3 (7%) |
T1 | 6 (15%) |
T2 | 13 (32%) |
T3 | 3 (7%) |
T4 | 11 (27%) |
Tx | 5 (12%) |
pN Classification | |
N0 | 23 (56%) |
N1 | 4 (10%) |
N2 | 7 (17%) |
Nx | 7 (17%) |
Clinical Stage | |
0 | 3 (7%) |
I | 5 (12%) |
II | 8 (20%) |
III | 7 (17%) |
IV | 13 (32%) |
Not Stated | 5 (12%) |
Length of Stay (d) | |
Mean (SD) | 11.6 (5.5) |
Range | 4.0–29.0 |